Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-obesity Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prescription Drugs
1.2.3 OTC Drugs
1.3 Market by Application
1.3.1 Global Anti-obesity Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Men
1.3.3 Women
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anti-obesity Medicine Market Perspective (2016-2027)
2.2 Anti-obesity Medicine Growth Trends by Regions
2.2.1 Anti-obesity Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-obesity Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Anti-obesity Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Anti-obesity Medicine Industry Dynamic
2.3.1 Anti-obesity Medicine Market Trends
2.3.2 Anti-obesity Medicine Market Drivers
2.3.3 Anti-obesity Medicine Market Challenges
2.3.4 Anti-obesity Medicine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anti-obesity Medicine Players by Revenue
3.1.1 Global Top Anti-obesity Medicine Players by Revenue (2016-2021)
3.1.2 Global Anti-obesity Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Anti-obesity Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-obesity Medicine Revenue
3.4 Global Anti-obesity Medicine Market Concentration Ratio
3.4.1 Global Anti-obesity Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-obesity Medicine Revenue in 2020
3.5 Anti-obesity Medicine Key Players Head office and Area Served
3.6 Key Players Anti-obesity Medicine Product Solution and Service
3.7 Date of Enter into Anti-obesity Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-obesity Medicine Breakdown Data by Type
4.1 Global Anti-obesity Medicine Historic Market Size by Type (2016-2021)
4.2 Global Anti-obesity Medicine Forecasted Market Size by Type (2022-2027)

5 Anti-obesity Medicine Breakdown Data by Application
5.1 Global Anti-obesity Medicine Historic Market Size by Application (2016-2021)
5.2 Global Anti-obesity Medicine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anti-obesity Medicine Market Size (2016-2027)
6.2 North America Anti-obesity Medicine Market Size by Type
6.2.1 North America Anti-obesity Medicine Market Size by Type (2016-2021)
6.2.2 North America Anti-obesity Medicine Market Size by Type (2022-2027)
6.2.3 North America Anti-obesity Medicine Market Size by Type (2016-2027)
6.3 North America Anti-obesity Medicine Market Size by Application
6.3.1 North America Anti-obesity Medicine Market Size by Application (2016-2021)
6.3.2 North America Anti-obesity Medicine Market Size by Application (2022-2027)
6.3.3 North America Anti-obesity Medicine Market Size by Application (2016-2027)
6.4 North America Anti-obesity Medicine Market Size by Country
6.4.1 North America Anti-obesity Medicine Market Size by Country (2016-2021)
6.4.2 North America Anti-obesity Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Anti-obesity Medicine Market Size (2016-2027)
7.2 Europe Anti-obesity Medicine Market Size by Type
7.2.1 Europe Anti-obesity Medicine Market Size by Type (2016-2021)
7.2.2 Europe Anti-obesity Medicine Market Size by Type (2022-2027)
7.2.3 Europe Anti-obesity Medicine Market Size by Type (2016-2027)
7.3 Europe Anti-obesity Medicine Market Size by Application
7.3.1 Europe Anti-obesity Medicine Market Size by Application (2016-2021)
7.3.2 Europe Anti-obesity Medicine Market Size by Application (2022-2027)
7.3.3 Europe Anti-obesity Medicine Market Size by Application (2016-2027)
7.4 Europe Anti-obesity Medicine Market Size by Country
7.4.1 Europe Anti-obesity Medicine Market Size by Country (2016-2021)
7.4.2 Europe Anti-obesity Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anti-obesity Medicine Market Size (2016-2027)
8.2 Asia-Pacific Anti-obesity Medicine Market Size by Type
8.2.1 Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-obesity Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-obesity Medicine Market Size by Application
8.3.1 Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-obesity Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-obesity Medicine Market Size by Region
8.4.1 Asia-Pacific Anti-obesity Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-obesity Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anti-obesity Medicine Market Size (2016-2027)
9.2 Latin America Anti-obesity Medicine Market Size by Type
9.2.1 Latin America Anti-obesity Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Anti-obesity Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Anti-obesity Medicine Market Size by Type (2016-2027)
9.3 Latin America Anti-obesity Medicine Market Size by Application
9.3.1 Latin America Anti-obesity Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Anti-obesity Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Anti-obesity Medicine Market Size by Application (2016-2027)
9.4 Latin America Anti-obesity Medicine Market Size by Country
9.4.1 Latin America Anti-obesity Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Anti-obesity Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anti-obesity Medicine Market Size (2016-2027)
10.2 Middle East & Africa Anti-obesity Medicine Market Size by Type
10.2.1 Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-obesity Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-obesity Medicine Market Size by Application
10.3.1 Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-obesity Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-obesity Medicine Market Size by Country
10.4.1 Middle East & Africa Anti-obesity Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-obesity Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Alizyme
11.1.1 Alizyme Company Details
11.1.2 Alizyme Business Overview
11.1.3 Alizyme Anti-obesity Medicine Introduction
11.1.4 Alizyme Revenue in Anti-obesity Medicine Business (2016-2021)
11.1.5 Alizyme Recent Development
11.2 Amylin Pharmaceuticals
11.2.1 Amylin Pharmaceuticals Company Details
11.2.2 Amylin Pharmaceuticals Business Overview
11.2.3 Amylin Pharmaceuticals Anti-obesity Medicine Introduction
11.2.4 Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021)
11.2.5 Amylin Pharmaceuticals Recent Development
11.3 Arena Pharmaceuticals
11.3.1 Arena Pharmaceuticals Company Details
11.3.2 Arena Pharmaceuticals Business Overview
11.3.3 Arena Pharmaceuticals Anti-obesity Medicine Introduction
11.3.4 Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021)
11.3.5 Arena Pharmaceuticals Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Anti-obesity Medicine Introduction
11.4.4 Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2016-2021)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Eisai
11.5.1 Eisai Company Details
11.5.2 Eisai Business Overview
11.5.3 Eisai Anti-obesity Medicine Introduction
11.5.4 Eisai Revenue in Anti-obesity Medicine Business (2016-2021)
11.5.5 Eisai Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Anti-obesity Medicine Introduction
11.6.4 GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Orexigen Therapeutics
11.7.1 Orexigen Therapeutics Company Details
11.7.2 Orexigen Therapeutics Business Overview
11.7.3 Orexigen Therapeutics Anti-obesity Medicine Introduction
11.7.4 Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2016-2021)
11.7.5 Orexigen Therapeutics Recent Development
11.8 Vivus
11.8.1 Vivus Company Details
11.8.2 Vivus Business Overview
11.8.3 Vivus Anti-obesity Medicine Introduction
11.8.4 Vivus Revenue in Anti-obesity Medicine Business (2016-2021)
11.8.5 Vivus Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Anti-obesity Medicine Introduction
11.9.4 Pfizer Revenue in Anti-obesity Medicine Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Anti-obesity Medicine Introduction
11.10.4 Roche Revenue in Anti-obesity Medicine Business (2016-2021)
11.10.5 Roche Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Anti-obesity Medicine Introduction
11.11.4 Merck Revenue in Anti-obesity Medicine Business (2016-2021)
11.11.5 Merck Recent Development
11.12 Novo Nordisk
11.12.1 Novo Nordisk Company Details
11.12.2 Novo Nordisk Business Overview
11.12.3 Novo Nordisk Anti-obesity Medicine Introduction
11.12.4 Novo Nordisk Revenue in Anti-obesity Medicine Business (2016-2021)
11.12.5 Novo Nordisk Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Anti-obesity Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prescription Drugs
Table 3. Key Players of OTC Drugs
Table 4. Global Anti-obesity Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Anti-obesity Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti-obesity Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Anti-obesity Medicine Market Share by Regions (2016-2021)
Table 8. Global Anti-obesity Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Anti-obesity Medicine Market Share by Regions (2022-2027)
Table 10. Anti-obesity Medicine Market Trends
Table 11. Anti-obesity Medicine Market Drivers
Table 12. Anti-obesity Medicine Market Challenges
Table 13. Anti-obesity Medicine Market Restraints
Table 14. Global Anti-obesity Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Anti-obesity Medicine Market Share by Players (2016-2021)
Table 16. Global Top Anti-obesity Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-obesity Medicine as of 2020)
Table 17. Ranking of Global Top Anti-obesity Medicine Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Anti-obesity Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti-obesity Medicine Product Solution and Service
Table 21. Date of Enter into Anti-obesity Medicine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Anti-obesity Medicine Revenue Market Share by Type (2016-2021)
Table 25. Global Anti-obesity Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Anti-obesity Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Anti-obesity Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Anti-obesity Medicine Revenue Market Share by Application (2016-2021)
Table 29. Global Anti-obesity Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Anti-obesity Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anti-obesity Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Anti-obesity Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 61. Alizyme Company Details
Table 62. Alizyme Business Overview
Table 63. Alizyme Anti-obesity Medicine Product
Table 64. Alizyme Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 65. Alizyme Recent Development
Table 66. Amylin Pharmaceuticals Company Details
Table 67. Amylin Pharmaceuticals Business Overview
Table 68. Amylin Pharmaceuticals Anti-obesity Medicine Product
Table 69. Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 70. Amylin Pharmaceuticals Recent Development
Table 71. Arena Pharmaceuticals Company Details
Table 72. Arena Pharmaceuticals Business Overview
Table 73. Arena Pharmaceuticals Anti-obesity Medicine Product
Table 74. Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 75. Arena Pharmaceuticals Recent Development
Table 76. Boehringer Ingelheim Company Details
Table 77. Boehringer Ingelheim Business Overview
Table 78. Boehringer Ingelheim Anti-obesity Medicine Product
Table 79. Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 80. Boehringer Ingelheim Recent Development
Table 81. Eisai Company Details
Table 82. Eisai Business Overview
Table 83. Eisai Anti-obesity Medicine Product
Table 84. Eisai Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 85. Eisai Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Anti-obesity Medicine Product
Table 89. GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Orexigen Therapeutics Company Details
Table 92. Orexigen Therapeutics Business Overview
Table 93. Orexigen Therapeutics Anti-obesity Medicine Product
Table 94. Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 95. Orexigen Therapeutics Recent Development
Table 96. Vivus Company Details
Table 97. Vivus Business Overview
Table 98. Vivus Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 99. Vivus Recent Development
Table 100. Pfizer Company Details
Table 101. Pfizer Business Overview
Table 102. Pfizer Anti-obesity Medicine Product
Table 103. Pfizer Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 104. Pfizer Recent Development
Table 105. Roche Company Details
Table 106. Roche Business Overview
Table 107. Roche Anti-obesity Medicine Product
Table 108. Roche Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 109. Roche Recent Development
Table 110. Merck Company Details
Table 111. Merck Business Overview
Table 112. Merck Anti-obesity Medicine Product
Table 113. Merck Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 114. Merck Recent Development
Table 115. Novo Nordisk Company Details
Table 116. Novo Nordisk Business Overview
Table 117. Novo Nordisk Anti-obesity Medicine Product
Table 118. Novo Nordisk Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 119. Novo Nordisk Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-obesity Medicine Market Share by Type: 2020 VS 2027
Figure 2. Prescription Drugs Features
Figure 3. OTC Drugs Features
Figure 4. Global Anti-obesity Medicine Market Share by Application: 2020 VS 2027
Figure 5. Men Case Studies
Figure 6. Women Case Studies
Figure 7. Anti-obesity Medicine Report Years Considered
Figure 8. Global Anti-obesity Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Anti-obesity Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Anti-obesity Medicine Market Share by Regions: 2020 VS 2027
Figure 11. Global Anti-obesity Medicine Market Share by Regions (2022-2027)
Figure 12. Global Anti-obesity Medicine Market Share by Players in 2020
Figure 13. Global Top Anti-obesity Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-obesity Medicine as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Anti-obesity Medicine Revenue in 2020
Figure 15. Global Anti-obesity Medicine Revenue Market Share by Type (2016-2021)
Figure 16. Global Anti-obesity Medicine Revenue Market Share by Type (2022-2027)
Figure 17. North America Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 19. North America Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 20. North America Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 21. United States Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 25. Europe Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 26. Europe Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 27. Germany Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Anti-obesity Medicine Market Share by Region (2016-2027)
Figure 37. China Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 45. Latin America Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 46. Latin America Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 47. Mexico Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 53. Turkey Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Alizyme Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 57. Amylin Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 58. Arena Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 60. Eisai Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 62. Orexigen Therapeutics Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 63. Vivus Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 67. Novo Nordisk Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed